Patents Assigned to ALLAKOS INC.
-
Patent number: 11912766Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec-7 antibodies that have reduced effector function.Type: GrantFiled: January 11, 2019Date of Patent: February 27, 2024Assignee: Allakos, Inc.Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic
-
Patent number: 11773162Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec7 antibodies.Type: GrantFiled: August 4, 2017Date of Patent: October 3, 2023Assignee: Allakos, Inc.Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic, Suzy El Bader, Kenneth Luehrsen
-
Publication number: 20220380460Abstract: The present disclosure provides methods for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia. In particular, the present disclosure provides methods for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia.Type: ApplicationFiled: October 23, 2020Publication date: December 1, 2022Applicant: Allakos Inc.Inventors: Bhupinder SINGH, Amol KAMBOJ, Henrik RASMUSSEN
-
Publication number: 20220331412Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.Type: ApplicationFiled: January 26, 2022Publication date: October 20, 2022Applicant: Allakos Inc.Inventors: Christopher R. BEBBINGTON, Rustom FALAHATI, Carolina Rita SOUSA FERNANDES, David John MATTHEWS, Nenad TOMASEVIC, Jason WILLIAMS, John LEUNG
-
Patent number: 11203638Abstract: The present disclosure provides methods for the treatment of an allergic ocular disease (e.g., allergic conjunctivitis, keratoconjunctivitis, or giant papillary conjunctivitis). In particular, the present disclosure provides methods for the treatment of an allergic ocular disease through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of an allergic ocular disease.Type: GrantFiled: May 4, 2018Date of Patent: December 21, 2021Assignee: ALLAKOS INC.Inventors: Christopher Robert Bebbington, Bradford Andrew Youngblood, Nenad Tomasevic
-
Patent number: 10774145Abstract: The invention provides methods and compositions for the prevention or treatment of fibrotic diseases such as idiopathic pulmonary fibrosis and pre-fibrotic diseases such as chronic hypersensitivity pneumonitis. In particular, the invention provides methods for the prevention or treatment of fibrotic diseases and pre-fibrotic diseases through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention or treatment fibrotic diseases such as idiopathic pulmonary fibrosis and pre-fibrotic diseases such as chronic hypersensitivity pneumonitis.Type: GrantFiled: June 16, 2016Date of Patent: September 15, 2020Assignee: Allakos Inc.Inventors: Christopher Robert Bebbington, Nenad Tomasevic, Rustom Falahati, Bradford Andrew Youngblood
-
Patent number: 10604577Abstract: The invention provides methods and compositions for the prevention and treatment of advanced systemic mastocytosis such as systemic mastocytosis with an associated hematologic non-mast-cell lineage disease (SM-AHNMD). In particular, the invention provides methods for the prevention and treatment of advanced systemic mastocytosis through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention and treatment of advanced systemic mastocytosis such as SM-AHNMD.Type: GrantFiled: October 20, 2016Date of Patent: March 31, 2020Assignee: Allakos Inc.Inventors: Christopher Robert Bebbington, Nenad Tomasevic, Rustom Falahati
-
Publication number: 20200054723Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.Type: ApplicationFiled: May 17, 2019Publication date: February 20, 2020Applicant: Allakos Inc.Inventors: Christopher R. BEBBINGTON, Rustom FALAHATI, Carolina Rita SOUSA FERNANDES, David John MATTHEWS, Nenad TOMASEVIC, Jason WILLIAMS, John LEUNG
-
Publication number: 20190338027Abstract: The present disclosure provides methods for the treatment of chronic obstructive pulmonary disease (COPD) (e.g., non-eosinophilic COPD). In particular, the present disclosure provides methods for the treatment of COPD (e.g., non-eosinophilic COPD) through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of COPD (e.g., non-eosinophilic COPD).Type: ApplicationFiled: January 5, 2018Publication date: November 7, 2019Applicant: Allakos Inc.Inventors: Bradford Andrew YOUNGBLOOD, Nenad TOMASEVIC, Christopher Robert BEBBINGTON
-
Patent number: 10183996Abstract: The invention provides methods and compositions for the prevention and treatment of Siglec-8 associated diseases such as chronic rhino sinusitis with concomitant asthma and aspirin-exacerbated respiratory disease. In particular, the invention provides methods for the prevention and treatment of Siglec-8 associated diseases through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention and treatment of Siglec-8 associated diseases such as chronic rhinosinusitis with concomitant asthma and aspirin-exacerbated respiratory disease.Type: GrantFiled: February 27, 2015Date of Patent: January 22, 2019Assignee: Allakos Inc.Inventors: Christopher Robert Bebbington, Nenad Tomasevic, Rustom Falahati
-
Publication number: 20170209556Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.Type: ApplicationFiled: December 7, 2016Publication date: July 27, 2017Applicant: Allakos Inc.Inventors: Christopher R. BEBBINGTON, Rustom FALAHATI, Carolina Rita SOUSA FERNANDES, David John MATTHEWS, Nenad TOMASEVIC, Jason WILLIAMS, John LEUNG
-
Patent number: 9546215Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.Type: GrantFiled: December 9, 2014Date of Patent: January 17, 2017Assignee: ALLAKOS INC.Inventors: Christopher R. Bebbington, Rustom Falahati, Carolina Rita Sousa Fernandes, David John Matthews, Nenad Tomasevic, Jason Williams, John Leung
-
Publication number: 20150203578Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.Type: ApplicationFiled: December 9, 2014Publication date: July 23, 2015Applicant: ALLAKOS INC.Inventors: CHRISTOPHER R. BEBBINGTON, RUSTOM FALAHATI, CAROLINA RITA SOUSA FERNANDES, DAVID JOHN MATTHEWS, NENAD TOMASEVIC, JASON WILLIAMS, JOHN LEUNG